"I’m not a huge fan of going to doctor’s offices. Working with Dr. Brown and her team I’ve seen the attention to new technologies and enhancements. I’ve been introduced to ideas that I didn’t think were even possible. Some of the work with stem cells has just amazed me and we have put it to the test."  -SA


Faster healing, quicker recovery, scarring eliminated — regenerative medicine treatments are a welcome addition to surgical procedures. Stem cell-based therapy has been proposed as an enabling alternative not only for the treatment of diseases, but also for the regeneration of tissues beyond complex surgical treatments or tissue transplantation.

Regenerative tissue such as amniotic tissues and Wharton’s Jelly umbilical cord tissues facilitate many surgical procedures and practices, including:

The Revolution Biologics Difference

All natural products

Development ensures there is no risk of cell rejection by recipient

Distinct differences when compared to traditional amniotic tissue

  • Our Wharton’s Jelly umbilical cord tissue products are obtained from healthy, carefully screened donors at the time of a scheduled cesarean section; these birth tissues would otherwise be discarded as medical waste
  • Tissue is packed with growth factors, cytokines, hyaluronic acid, and other stromal tissues (up to 50Xs more than amniotic tissue); promotes healing, repairs and reduces inflammation
  • Wharton’s Jelly tissue closest to baby is packed full of mesenchymal stem cells; tissue is not a blood product and is immune privileged

Because there are no RBCs, there is virtually no chance of alloreaction

Revolution Biologics-MSC is recovered from healthy, carefully screened mothers at the time of caesarean section. All protocols are in accordance with the FDA and the American Association of Tissue Banks (AATB) regulations and standards. Revolution Biologics-MSC is regulated as a human cell, tissue, or cellular or tissue- based product (HCT/P) under 21 CFR Part 1271 and Section 361 of the Public Health Service Act.)